The demand for at-home testing in Japan is projected to grow from USD 393.5 million in 2025 to USD 560.5 million by 2035, at a CAGR of 3.6%. Digital Monitoring Instruments will dominate with a 48.0% market share, while blood glucose testing will lead the application segment with a 50.0% share.